Description
Composition (Each ml contains):
-
Carboxymethylcellulose Sodium: 0.5% w/v
-
Stabilized Oxychloro Complex (as preservative): q.s.
-
Sterile Aqueous Ophthalmic Base: q.s.
Dosage Form: Ophthalmic Solution (Eye Drops)
Therapeutic Class: Ocular Lubricant / Artificial Tears
(Preservative System for Dry Eye Management)
Frequently Asked Questions
Q: What is the role of stabilized oxychloro complex as a preservative?
A: It offers antimicrobial security by breaking down into innocuous chemicals upon coming into contact with the eye, reducing the need for preservation and causing irritation to the eyes.
Q: Can this formulation be used frequently daily with great regularity in long-term chronic patients with dry eye?
A: Yes, it has an equal viscosity and mild preservative system to apply over and over again without causing the ocular surface to be seriously disturbed.
Q: What are other eye drugs that can be combined with these eye drops?
A: They may be applied as support therapy, although it is advisable to allow a proper time between various eye drugs to prevent a dilution or interaction effect.
Q. Does the ophthalmic base have any effect on the clarity of vision after instillation?
A: To facilitate comfortable daytime wearing, the aqueous sterile base provides a well-spread of drops with little transient blurring effects.
Q: Which effect can this formulation have on patients with a strain on the eye caused by the screen?
A: It restores tear film stability, featured by the minimization of dryness and irritation due to excessive exposure to digital screens.
Q: What are the quality control measures that Knox Lifesciences is adhering to regarding ophthalmic solutions?
A: There follow GMP-WHO- manufacturing norms, whose sterility, stability, and consistency are examined rigorously to enhance the ophthalmic safety standards.
